| | Reference | Published | View |
|---|
| Gancheva 2022 Diabetes Care | Gancheva S, Kahl S, Pesta D, Mastrototaro L, Dewidar B, Strassburger K, Sabah E, Esposito I, Weiß J, Sarabhai T, Wolkersdorfer M, Fleming T, Nawroth P, Zimmermann M, Reichert AS, Schlensak M, Roden M (2022) Impaired hepatic mitochondrial capacity in nonalcoholic steatohepatitis associated with type 2 diabetes. https://doi.org/10.2337/dc21-1758 | 2022 | Diabetes Care 45:928-37. PMID: 35113139 |
| Zweck 2021 Diabetes Care | Zweck E, Scheiber D, Jelenik T, Bönner F, Horn P, Pesta D, Schultheiss HP, Boeken U, Akhyari P, Lichtenberg A, Kelm M, Roden M, Westenfeld R, Szendroedi J (2021) Exposure to type 2 diabetes provokes mitochondrial impairment in apparently healthy human hearts. Diabetes Care 44:e82-e84. | 2021 | PMID: 33972315 |
| Timmers 2016 Diabetes Care | Timmers S, de Ligt M, Phielix E, van de Weijer T, Hansen J, Moonen-Kornips E, Schaart G, Kunz I, Hesselink MK, Schrauwen-Hinderling VB, Schrauwen P (2016) Resveratrol as add-on therapy in subjects with well-controlled type 2 diabetes: a randomized controlled trial. Diabetes Care 39:2211-17. | 2016 | PMID: 27852684 Open Access |
| Jørgensen 2002 Diabetes Care | Jørgensen ME, Bjeregaard P, Borch-Johnsen K (2002) Diabetes and impaired glucose tolerance among the inuit population of Greenland. Diabetes Care 25: 1766-1771. | 2002 | PMID: 12351475 Open Access |
